Osaka / Helsinki / Fullerton / Kyoto / Hyogo / Bergisch Gradbach / Vienna / San Diego / Rockford / /
Company
Cooperative Oncology Group / Japanese Clinical Oncology Group / Beckman Coulter Inc. / Miltenyi Biotec GmbH / Google / Novartis Pharmaceuticals / Ford / HP / Creative Commons / BioMed Central Ltd. / BD Biosciences / /
Country
Germany / Japan / Austria / / /
Event
FDA Phase / /
Facility
Kobe University Hospital / Kyoto University / Kyoto University Hospital / Nagasaki University / Kansai Medical University Hirakata Hospital / Kyoto Prefectural University of Medicine / /
IndustryTerm
study protocol / Cancer Treat / imaging / oncology / treatment of postmenopausal breast cancer / therapy for early breast cancer / online submission / /
MarketIndex
Preoperative Endocrine Prognostic / /
MedicalCondition
positive primary breast cancer / solid tumours / N0M0 breast cancer / sensitized target tumor / invasive ductal cancer / Metastasis / estrogen receptor-positive breast cancer / hyperparathyroidism / early breast cancer / Solid Tumors / J Cancer / hormone receptor-positive breast cancer / inflammatory cytokines / postmenopausal breast cancer / periodontal disease / lymph node metastasis / breast cancer / DISH / tumor / early-stage breast cancer / breast cancers / measurable disease / Cancer / postneoadjuvant endocrine therapy tumor / disease / HER2-negative breast cancer / T2 N0M0 breast cancer / tumour / fever / invasive breast cancer / diseases / deficiency / uncontrolled diabetes mellitus / pathological tumor / /
Japanese Breast Cancer Society / Medical University Hirakata Hospital / Graduate School / Department of Clinical Innovative Medicine / African Union / Kyoto Prefectural University of Medicine / Kyoto / European Society of Breast Imaging / Institute for Advancement of Clinical and Translational Science / Kyoto University / Kobe University Hospital / Nagasaki University / Kyoto University Hospital / Ministry of Education / World Medical Association / Kyoto University / Kyoto / Ministry of Health / /
Person
Gracia Marco / Lopez Garcia-Asenjo / Ann Oncol / Mel JR / /
Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs